These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 38169282)
21. Viable but Nonculturable and Persister Cells Coexist Stochastically and Are Induced by Human Serum. Ayrapetyan M; Williams TC; Baxter R; Oliver JD Infect Immun; 2015 Nov; 83(11):4194-203. PubMed ID: 26283335 [TBL] [Abstract][Full Text] [Related]
22. Dormancy is not necessary or sufficient for bacterial persistence. Orman MA; Brynildsen MP Antimicrob Agents Chemother; 2013 Jul; 57(7):3230-9. PubMed ID: 23629720 [TBL] [Abstract][Full Text] [Related]
23. Deacylated tRNA Accumulation Is a Trigger for Bacterial Antibiotic Persistence Independent of the Stringent Response. Wood WN; Mohler K; Rinehart J; Ibba M mBio; 2021 Jun; 12(3):e0113221. PubMed ID: 34126764 [TBL] [Abstract][Full Text] [Related]
24. Genetic basis of persister tolerance to aminoglycosides in Escherichia coli. Shan Y; Lazinski D; Rowe S; Camilli A; Lewis K mBio; 2015 Apr; 6(2):. PubMed ID: 25852159 [TBL] [Abstract][Full Text] [Related]
25. Medium chain unsaturated fatty acid ethyl esters inhibit persister formation of Escherichia coli via antitoxin HipB. Wang M; Fang K; Hong SMC; Kim I; Jang IS; Hong SH Appl Microbiol Biotechnol; 2018 Oct; 102(19):8511-8524. PubMed ID: 30088019 [TBL] [Abstract][Full Text] [Related]
26. Rv2744c Is a PspA Ortholog That Regulates Lipid Droplet Homeostasis and Nonreplicating Persistence in Mycobacterium tuberculosis. Armstrong RM; Adams KL; Zilisch JE; Bretl DJ; Sato H; Anderson DM; Zahrt TC J Bacteriol; 2016 Jun; 198(11):1645-1661. PubMed ID: 27002134 [TBL] [Abstract][Full Text] [Related]
27. (p)ppGpp-Dependent Persisters Increase the Fitness of Escherichia coli Bacteria Deficient in Isoaspartyl Protein Repair. VandenBerg KE; Ahn S; Visick JE Appl Environ Microbiol; 2016 Sep; 82(17):5444-54. PubMed ID: 27371580 [TBL] [Abstract][Full Text] [Related]
28. Active efflux in dormant bacterial cells - New insights into antibiotic persistence. Pu Y; Ke Y; Bai F Drug Resist Updat; 2017 Jan; 30():7-14. PubMed ID: 28363336 [TBL] [Abstract][Full Text] [Related]
29. Molecular reprogramming and phenotype switching in Huemer M; Mairpady Shambat S; Bergada-Pijuan J; Söderholm S; Boumasmoud M; Vulin C; Gómez-Mejia A; Antelo Varela M; Tripathi V; Götschi S; Marques Maggio E; Hasse B; Brugger SD; Bumann D; Schuepbach RA; Zinkernagel AS Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33574060 [No Abstract] [Full Text] [Related]
30. Prophages and Growth Dynamics Confound Experimental Results with Antibiotic-Tolerant Persister Cells. Harms A; Fino C; Sørensen MA; Semsey S; Gerdes K mBio; 2017 Dec; 8(6):. PubMed ID: 29233898 [TBL] [Abstract][Full Text] [Related]
31. Protein aggregation is a consequence of the dormancy-inducing membrane toxin TisB in Leinberger FH; Cassidy L; Edelmann D; Schmid NE; Oberpaul M; Blumenkamp P; Schmidt S; Natriashvili A; Ulbrich MH; Tholey A; Koch H-G; Berghoff BA mSystems; 2024 Nov; 9(11):e0106024. PubMed ID: 39377584 [TBL] [Abstract][Full Text] [Related]
32. The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy. Jõers A; Kaldalu N; Tenson T J Bacteriol; 2010 Jul; 192(13):3379-84. PubMed ID: 20435730 [TBL] [Abstract][Full Text] [Related]
33. Selective target inactivation rather than global metabolic dormancy causes antibiotic tolerance in uropathogens. Goneau LW; Yeoh NS; MacDonald KW; Cadieux PA; Burton JP; Razvi H; Reid G Antimicrob Agents Chemother; 2014; 58(4):2089-97. PubMed ID: 24449771 [TBL] [Abstract][Full Text] [Related]
34. Identification of Novel Genes Involved in Li T; Wang J; Cao Q; Li F; Han J; Zhu B; Zhang Y; Niu H Front Cell Infect Microbiol; 2020; 10():581986. PubMed ID: 33117736 [TBL] [Abstract][Full Text] [Related]
35. Heterologous Protein Expression Favors the Formation of Protein Aggregates in Persister and Viable but Nonculturable Bacteria. Goode O; Smith A; Łapińska U; Bamford R; Kahveci Z; Glover G; Attrill E; Carr A; Metz J; Pagliara S ACS Infect Dis; 2021 Jun; 7(6):1848-1858. PubMed ID: 34000805 [TBL] [Abstract][Full Text] [Related]
37. PhoU is a persistence switch involved in persister formation and tolerance to multiple antibiotics and stresses in Escherichia coli. Li Y; Zhang Y Antimicrob Agents Chemother; 2007 Jun; 51(6):2092-9. PubMed ID: 17420206 [TBL] [Abstract][Full Text] [Related]
38. Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence. Luidalepp H; Jõers A; Kaldalu N; Tenson T J Bacteriol; 2011 Jul; 193(14):3598-605. PubMed ID: 21602347 [TBL] [Abstract][Full Text] [Related]
39. Experimental Evolution of Escherichia coli Persister Levels Using Cyclic Antibiotic Treatments. Van den Bergh B; Michiels JE; Michiels J Methods Mol Biol; 2016; 1333():131-43. PubMed ID: 26468106 [TBL] [Abstract][Full Text] [Related]